Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancer (Q80274030)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16979430%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16979430%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

main subject

phase III clinical trial

1 reference

1 reference

1

Ignace Vergote

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16979430%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

2

Frederic Amant

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16979430%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16979430%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16979430%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16979430%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16979430%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

415-417

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16979430%20AND%20SRC:MED&resulttype=core&format=json

Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.001

Systematic review of adjuvant therapy for early stage (epithelial) ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.001

Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.001

Randomized trial comparing cisplatin with radioactive phosphorus or whole-abdomen irradiation as adjuvant treatment of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.001

Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia Oncologica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.001

Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.001

Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.001

Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.001

Analysis of prognostic factors in stage I epithelial ovarian carcinoma: importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.001

Prognostic significance of cell DNA content in early-stage ovarian cancer (FIGO stages I and II/A) by means of automatic image cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.001

DNA index reflects the biological behavior of ovarian carcinoma stage I-IIa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.001

DNA-ploidy as an independent prognostic factor in patients with serous ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.001

Treatment of patients with early epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.001

Flow cytometric evaluation of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2006.08.001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16979430%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference